NCT00286507View on ClinicalTrials.gov

Full Thickness Macular Hole and Internal Limiting Membrane Peeling Study

NACompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2011

Conditions
Stage 2 or 3 Full Thickness Macular Hole
Interventions
PROCEDURE

Vitrectomy, post hyaloid detachment and gas injection with or without ILM peel.

Combined cataract surgery (phacoemulsification and intraocular lens implantation) and pars plana vitrectomy with postoperative intraocular tamponade with gas, with or without ILM peeling

Trial Locations (9)

Unknown

Royal Victoria Eye and Ear Hospital, Dublin

Waterford Regional Hospital, Waterford

Aberdeen Royal Infirmary, Aberdeen

Bristol Eye Hospital, Bristol

Ninewells Hospital, Dundee

Gartnavel General Hospital, Glasgow

Royal Liverpool Hospital, Liverpool

Oxford Eye Hospital, Oxford

Sunderland Eye Infirmary, Sunderland

All Listed Sponsors
collaborator

NHS Grampian

OTHER_GOV

collaborator

Chief Scientist Office of the Scottish Government

OTHER_GOV

lead

University of Aberdeen

OTHER

NCT00286507 - Full Thickness Macular Hole and Internal Limiting Membrane Peeling Study | Biotech Hunter | Biotech Hunter